Spectrum Pharmaceuticals Other Liabilities

As of the most recent data (March 2023), SPPI shows a other liabilities of $0. That compares with $5.6M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SPPI's other liabilities is now $0 (was $5.6M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Spectrum Pharmaceuticals is outperforming or lagging.

Tracking SPPI's other liabilities over time shows whether Spectrum Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $5.6M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Spectrum Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Spectrum Pharmaceuticals's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.